As per FMI – an ESOMAR-certified market research firm, the global pharmaceutical lipids market is expected to witness a CAGR of over 5.2% and surpass USD 7 Bn by 2031.The pharmaceutical lipids market players are focusing on Lipid nanocarriers are being increasingly used in the form of drug delivery systems as they a.
In drug development many applications are found for lipid-based nanoparticles (Lb-NPs) as successful transporters
for poorly water-soluble drugs and oligonucleotides in gene therapy.
Major advantages of lipids are their
high biocompatibility and biodegradability. In addition, advanced formulations using Lb-NP encapsulation of active ingredients can strongly contribute to targeted drug delivery in the body as well as stability and storage of the formulation.
The most important current medical applications include
cancer therapeutics and some of the current
COVID-19 vaccines.
Development and manufacturing of Lb-NP products often involves complex processes that need to be thoroughly understood and controlled to ensure optimum and constant quality of the medicine for patients. Therefore,